Low-Sensitivity FDG-PET Studies: Less Common Lung Neoplasms

Seminars in Nuclear Medicine, 06/08/2012

This article reviews the use of positron emission tomography (PET) in patients with these uncommon lung neoplasms as well as radiotracers that have been developed to interrogate different metabolic pathways, receptors, and targets to overcome the potential limitations of FDG–PET in the diagnosis, staging, as well as early response evaluation and monitoring of response to targeted therapies.

Print Article Summary Cat 2 CME Report